Who owns NEUROBO PHARMACEUTICALS INC?
- Ticker: NRBO
- CUSIP Number: 64132r404
Tip: Access positions for across all investors
Analyze quarterly positions in Neurobo Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Neurobo Pharmaceuticals stock
Who bought or sold NEUROBO PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Armistice Capital | 697k | $3.4M | 100% | Jun 2024 |
|
| Affinity Asset Advisors | 89k | $283k | 0% | Sep 2024 |
|
| Vanguard Group | 47k | $229k | 69% | Jun 2024 |
|
| Geode Capital Management | 33k | $103k | 41% | Sep 2024 |
|
| Ferguson Wellman Capital Management | 16k | $50k | 100% | Sep 2024 |
|
| State Street Corporation | 16k | $76k | 0% | Jun 2024 |
|
| Northern Trust | 14k | $43k | 0% | Sep 2024 |
|
| BlackRock | 5.3k | $26k | 0% | Jun 2024 |
|
| BlackRock | 5.3k | $17k | 100% | Sep 2024 |
|
| Tower Research Capital | 1.0k | $4.9k | -38% | Jun 2024 |
|
| Bank of America Corporation | 30.00 | $95.172000 | -81% | Sep 2024 |
|
| Morgan Stanley | 25.00 | $121.000000 | 0% | Jun 2024 |
|
| Jpmorgan Chase & Co | 7.00 | $22.000300 | 40% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 4.00 | $13.000000 | 0% | Sep 2024 |
|